These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21533915)

  • 1. Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy.
    van den Wijngaard A; Volders P; Van Tintelen JP; Jongbloed JD; van den Berg MP; Lekanne Deprez RH; Mannens MM; Hofmann N; Slegtenhorst M; Dooijes D; Michels M; Arens Y; Jongbloed R; Smeets BJ
    Neth Heart J; 2011 Aug; 19(7-8):344-51. PubMed ID: 21533915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report: Twin sisters with restrictive cardiomyopathy associated with rare mutations in the cardiac troponin I gene.
    Ueno M; Takeda A; Yamazawa H; Takei K; Furukawa T; Suzuki Y; Chida-Nagai A; Kimura A
    J Cardiol Cases; 2021 Apr; 23(4):154-157. PubMed ID: 33841591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
    Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy.
    Fahed AC; Nemer G; Bitar FF; Arnaout S; Abchee AB; Batrawi M; Khalil A; Abou Hassan OK; DePalma SR; McDonough B; Arabi MT; Ware JS; Seidman JG; Seidman CE
    Circ Genom Precis Med; 2020 Oct; 13(5):444-452. PubMed ID: 32885985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation.
    Hwang JW; Jang MA; Jang SY; Seo SH; Seong MW; Park SS; Ki CS; Kim DK
    Korean Circ J; 2017 Mar; 47(2):270-277. PubMed ID: 28382084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.
    Otten E; Lekanne Dit Deprez RH; Weiss MM; van Slegtenhorst M; Joosten M; van der Smagt JJ; de Jonge N; Kerstjens-Frederikse WS; Roofthooft MT; Balk AH; van den Berg MP; Ruiter JS; van Tintelen JP
    Neth Heart J; 2010 Oct; 18(10):478-85. PubMed ID: 20978592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous
    Sorrentino U; Gabbiato I; Canciani C; Calosci D; Rigon C; Zuccarello D; Cassina M
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
    Carballo S; Robinson P; Otway R; Fatkin D; Jongbloed JD; de Jonge N; Blair E; van Tintelen JP; Redwood C; Watkins H
    Circ Res; 2009 Aug; 105(4):375-82. PubMed ID: 19590045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.
    Mogensen J; Kubo T; Duque M; Uribe W; Shaw A; Murphy R; Gimeno JR; Elliott P; McKenna WJ
    J Clin Invest; 2003 Jan; 111(2):209-16. PubMed ID: 12531876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.
    Tadros HJ; Life CS; Garcia G; Pirozzi E; Jones EG; Datta S; Parvatiyar MS; Chase PB; Allen HD; Kim JJ; Pinto JR; Landstrom AP
    J Mol Cell Cardiol; 2020 May; 142():118-125. PubMed ID: 32278834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
    Zhang L; Ding F; Ren Z; Cheng W; Dai H; Liang Q; Kong F; Xu W; Zhang Y; Tao Q
    Int J Cardiol; 2024 Oct; ():132627. PubMed ID: 39426416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
    Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V
    Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy].
    Yang SW; Chen Y; Li J; Yin J; Qin YM; Andelfinger G; Wang DW; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Apr; 41(4):304-9. PubMed ID: 23906401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
    Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
    Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.